drugset / Trial / NCT00652106
Safety and Efficacy Study of Brimonidine/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study evaluates the safety and efficacy of brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution compared with concurrent brimonidine 0.2% and timolol ophthalmic solutions
Timeline
- Start
- 2003-06
- Primary completion
- 2004-03
- Completion
- 2004-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution | Unknown | 0.2 % | Other |
| Subject | 0.2% brimonidine/0.5% timolol fixed combination ophthalmic solution | Unknown | 0.5 % | Other |
| Comparator | Brimonidine | Small molecule | 0.2 % | Other |
| Comparator | Timolol | Other / unclassified | 0.5 % | Other |